L Aarden

10.9k citations

104 papers · 8.3k indexed · 3 hit papers · h-index 47

Immunology top 0.5%
- T-cell and B-cell Immunology 29
- Immune Cell Function and Interaction 15
- Immune Response and Inflammation 15
Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research 16
- Rheumatoid Arthritis Research and Therapies 11
Hematology top 0.5%
Radiology, Nuclear Medicine and Imaging top 0.5%
- Monoclonal and Polyclonal Antibodies Research 41
Immunology and Allergy top 1%
Oncology
- Cytokine Signaling Pathways and Interactions 12
Genetics
- Chronic Lymphocytic Leukemia Research 11

Co-authors: L C Boeije E R de Groot John Wijdenes T. E. W. Feltkamp R J Smeenk SJ van Deventer JW ten Cate Gertjan Wolbink
Cited by: Immunology Rheumatology Hematology
Journals: Annals of the Rheumatic Diseases (15 papers)The Journal of Immunology (11 papers)Blood (7 papers)
Partner nations: Netherlands United Kingdom United States

In The Last Decade

L Aarden

104 papers receiving 7.9k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by L Aarden

Since Specialization

Citations

This map shows the geographic impact of L Aarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Aarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Aarden more than expected).

Fields of papers citing papers by L Aarden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Aarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Aarden. The network helps show where L Aarden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside L Aarden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with L Aarden Line = papers co-authored together L Aarden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tissue factor pathway inhibitor is an inhibitor of factor VII‐activating protease Journal of Thrombosis and Haemostasis ·Frank Stephan,Natia Tchkadua,Ingrid Bulder,刘连荣,Alan E. Mast,Henk te Velthuis,L Aarden,Sacha Zeerleder	2012	14
2	Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis Annals of the Rheumatic Diseases ·Rogier M. Thurlings,胡锡骥,Koen Vos,Daniëlle M. Gerlag,L Aarden,Steven O. Stapel,Jacob M. van Laar,Paul P. Tak,Gertjan Wolbink	2009	89
3	Anti-infliximab and anti-adalimumab antibodies in relation to response to adalimumab in infliximab switchers and anti-tumour necrosis factor naive patients: a cohort study Annals of the Rheumatic Diseases ·G. M. Bartelds,Carla A. Wijbrandts,Michael T. Nurmohamed,Steven O. Stapel,Willem F. Lems,L Aarden,B.A.C. Dijkmans,Paul P. Tak,Gertjan Wolbink	2009	174
4	Decreased clinical response to infliximab in ankylosing spondylitis is correlated with anti-infliximab formation Annals of the Rheumatic Diseases ·Mirjam K. de Vries,Gertjan Wolbink,Steven O. Stapel,Mediaeval Antiquities,J. Christiaan van Denderen,B.A.C. Dijkmans,L Aarden,Irene van der Horst‐Bruinsma	2007	113
5	Activation of toll‐like receptors 2 and 4 by gram‐negative periodontal bacteria Oral Microbiology and Immunology ·Alfiatus Sholichah,Marja L. Laine,L Aarden,A.J. van Winkelhoff	2007	130
6	Imaging and serum analysis of immune complex formation of radiolabelled infliximab and anti-infliximab in responders and non-responders to therapy for rheumatoid arthritis Annals of the Rheumatic Diseases ·Conny J. van der Laken,Alexandre E. Voskuyl,Jan C. Roos,Spencer Dir,E R de Groot,Gertjan Wolbink,Ben A. C. Dijkmans,L Aarden	2006	147
7	Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis Annals of the Rheumatic Diseases ·M. Nielen,A. R. van der Horst,D. van Schaardenburg,Irene E. van der Horst‐Bruinsma,R J van de Stadt,L Aarden,B.A.C. Dijkmans,Dörte Hamann	2005	147
8	Clusterin: a protective mediator for ischemic cardiomyocytes? American Journal of Physiology-Heart and Circulatory Physiology ·Paul A.J. Krijnen,Saskia A.G.M. Cillessen,Priyaranjan Nandy,Alice Muller,C.A. Visser,Chris J.L.M. Meijer,René J.P. Musters,C. Erik Hack,L Aarden,Hans W.M. Niessen	2005	52
9	Do Elevated Levels of Serum-Soluble Fas Contribute to the Persistence of Activated Lymphocytes in Systemic Lupus Erythematosus? Journal of Autoimmunity ·Marc Bijl,Monica Koel Östbye,P. C. Limburg,PE Spronk,Sonja M.H.J. Jaegers,L Aarden,R J Smeenk,Augustin-Prosper Hacquard	1998	26
10	Regulation of IL‐12 Production by Human Monocytes and the Influence of Prostaglandin E₂ Annals of the New York Academy of Sciences ·Tineke C. T. M. van der Pouw Kraan,L C Boeije,A. J. Snijders,R J Smeenk,John Wijdenes,L Aarden	1996	30
11	Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon- gamma Blood ·PM Jansen,Troy A. James,Kim Sung Keen,Gerard van Mierlo,John Wijdenes,Haleh Rabiei,L Aarden,Е. Кузёма,C. Erik Hack	1996	70
12	Development of an interleukin (IL) 6 receptor antagonist that inhibits IL-6-dependent growth of human myeloma cells. The Journal of Experimental Medicine ·Floris D. de Hon,Marc Ehlers,Stefan Rose‐John,S B Ebeling,Wright K. Makambi,L Aarden,Just P. J. Brakenhoff	1994	45
13	On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. Journal of Clinical Investigation ·Paul W.H.I. Parren,P A Warmerdam,L C Boeije,J.A.J. Arts,N. A. C. Westerdaal,A Vlug,P J Capel,L Aarden,J G van de Winkel	1992	278
14	Induction of urinary interleukin-1 (IL-1), IL-2, IL-6, and tumour necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer Cancer Immunology Immunotherapy ·Elizabeth C. de Boer,Wim H. de Jong,P. A. Steerenberg,L Aarden,Eric Tetteroo,E R de Groot,A.P.M. van der Meijden,P. D. J. Vegt,F.M.J. Debruyne,E. J. Ruitenberg	1992	162
15	Induction of T-cell proliferation by recombinant mouse and chimeric mouse/human anti-CD3 monoclonal antibodies Research in Immunology ·Paul W.H.I. Parren,Marlieke Geerts,L C Boeije,L Aarden	1991	19
16	Cytokine-associated tissue injury and lethality in mice: A comparative study Clinical Immunology and Immunopathology ·M R Shalaby,Jostein Halgunset,Chelsea G Adams,Iben McCormick‐Ricket,L Aarden,Anders Waage,Kouji Matsushima,Jerzy Ronikier,Diana Boraschi,Jon Lamvik,Terje Espevik	1991	22
17	Interleukin-6 enhances human Ig production, but not as a terminal differentiation factor for B lymphocytes Research in Immunology ·Cees van Kooten,M. H. van Oers,L Aarden	1990	8
18	Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis Biochemical and Biophysical Research Communications ·Clemens W.G.M. Löwik,Gabri van der Pluijm,Marko Jovanovic,Klaas Hoekman,O. L. M. Bijvoet,L Aarden,Socrates E. Papapoulos	1989	316
19	Interleukin-6 (IL-6) and acute phase proteins in the disease course of patients with systemic lupus erythematosus Rheumatology International ·A. J. G. Swaak,Anthony van Rooyen,L Aarden	1989	47
20	lnterleukin-6 (IL-6) in Synovial Fluid and Serum of Patients with Rheumatic Diseases Scandinavian Journal of Rheumatology ·A. J. G. Swaak,Anthony van Rooyen,EES Nieuwenhuis,L Aarden	1988	120

About L Aarden

L Aarden is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Hematology, Rheumatology and Genetics, having authored 104 papers that have together received 8.3k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (41 papers), T-cell and B-cell Immunology (29 papers), Systemic Lupus Erythematosus Research (16 papers), Immune Cell Function and Interaction (15 papers), Immune Response and Inflammation (15 papers), Cytokine Signaling Pathways and Interactions (12 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Rheumatoid Arthritis Research and Therapies (11 papers). The work is most often cited by research in Immunology (4.1k citations), Rheumatology (1.7k citations), Hematology (1.2k citations), Radiology, Nuclear Medicine and Imaging (1.7k citations) and Immunology and Allergy (415 citations). L Aarden has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include L C Boeije, E R de Groot, John Wijdenes, T. E. W. Feltkamp, R J Smeenk, SJ van Deventer, JW ten Cate, Gertjan Wolbink, A. J. G. Swaak and C. Erik Hack. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Immunology, Blood, Journal of Immunological Methods and Clinical & Experimental Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact